Ryan J. Selhorn - Nov 11, 2024 Form 3 Insider Report for AYTU BIOPHARMA, INC (AYTU)

Role: Chief Financial Officer
Signature: /s/ Ryan J. Selhorn
Stock symbol: AYTU
Transactions as of: Nov 11, 2024
Transactions value $: $0
Form type: 3
Date filed: 11/13/2024, 04:08 PM
Next filing: Mar 3, 2025
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
holding	AYTU	Common Shares						1.9K	Nov 11, 2024	Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
holding	AYTU	Restricted Stock Units							Nov 11, 2024	Common Shares	105	$0.00	Direct	F1
holding	AYTU	Employee Stock Option (Right to Buy)							Nov 11, 2024	Common Shares	5.79K	$4.00	Direct	F2
holding	AYTU	Employee Stock Option (Right to Buy)							Nov 11, 2024	Common Shares	5K	$1.73	Direct	F3
holding	AYTU	Employee Stock Option (Right to Buy)							Nov 11, 2024	Common Shares	5K	$1.84	Direct	F4

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Restricted stock units ("RSUs"), each of which represents a contingent right to receive one share of the Issuer's common stock. The RSUs were granted February 5, 2022, vesting quarterly beginning February 5, 2023, and ending February 5, 2025, with 105 unvested RSUs remaining as of the date of filing of this Form 3.
F2	The options were granted October 1, 2022, and vest as follows: 1/3 on October 1, 2023, with the remaining options vesting in 24 equal monthly installments beginning November 1, 2023.
F3	The options were granted August 11, 2023, and vest as follows: 1/3 on August 11, 2024, with the remaining options vesting in 24 equal monthly installments beginning September 11, 2024.
F4	The options were granted on November 6, 2024, and vest as follows: 1/3 on November 6, 2025, with the remaining options vesting in 24 equal monthly installments beginning December 6, 2025.